×
AllNewsMapsImages Videos Shopping Books
Search tools
Did you mean: Collegium Pharma

Principal Securities Inc. Acquires Shares of 1303 Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Defense World
Read Principal Securities Inc. Acquires Shares of 1303 Collegium Pharmaceutical, Inc. (NASDAQ:COLL) at Defense World.
1 hour ago

How Good Is Collegium Pharmaceutical, Inc. (NASDAQ:COLL), When It Comes To ROE?

Yahoo Lifestyle Canada
While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...
3 days ago

Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall, 5/10/2024

ABC News - Breaking News, Latest News and Videos
Stocks that traded heavily or had substantial price changes on Friday: Sweetgreen, Natera rise; Collegium Pharmaceutical, Akamai fall.
2 weeks ago

Demystifying Collegium Pharmaceutical: Insights From 4 Analyst Reviews

markets.businessinsider.com
Throughout the last three months, 4 analysts have evaluated Collegium Pharmaceutical (NASDAQ:COLL), offering a diverse set of opinions from...
2 weeks ago

Collegium Pharmaceutical Q4: The Beat Goes On (NASDAQ:COLL)

Seeking Alpha
Collegium Pharmaceutical is located just outside of Boston in Stoughton, MA. The company is focused on the development of pain medications and...
3 months ago

Collegium Pharmaceutical CEO Joe Ciaffoni Steps Down

MarketWatch
By Mary de Wet Collegium Pharmaceutical President and Chief Executive Joe Ciaffoni is stepping down on May 24. The specialty pharmaceutical...
2 weeks ago

Federal Circuit Patent Watch: Avoid fighting with the courts and administrative agencies

WilmerHale
PURDUE PHARMA LP v. COLLEGIUM PHARMACEUTICAL, INC. [OPINION] (2022-1482, 11/21/2023) (Dyk, Hughes, and Stoll).
5 months ago

Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates

Zacks Investment Research
Collegium Pharmaceutical (COLL) delivered earnings and revenue surprises of -2.68% and 1.44%, respectively, for the quarter ended March 2024...
2 weeks ago

It Looks Like Shareholders Would Probably Approve Collegium Pharmaceutical, Inc.'s (NASDAQ:COLL) CEO Compensation Package

Simply Wall Street
Key Insights Collegium Pharmaceutical to hold its Annual General Meeting on 16th of May Salary of US$817.0k is part of...
2 weeks ago

Swiss National Bank Has $2.11 Million Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Defense World
Read Swiss National Bank Has $2.11 Million Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL) at Defense World.
1 day ago